| Financial Year |
March 31 2023 |
| Monetary Funds |
18,128,896,549.30 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,884,951,408.96 |
| Advances to Suppliers |
579,135,728.22 |
| Other Receivables |
66,688,315.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
698,911,411.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
434,831,082.43 |
| Total Current Assets |
22,180,813,829.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,268,565,595.69 |
| Investment Properties |
-- |
| Fixed Assetes |
22,866,879,451.61 |
| Under-construction Projects |
12,752,219,907.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,244,052,251.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
42,966,755.22 |
| Deferred Income Tax Assets |
993,347,025.80 |
| Other Non-Current Assets |
3,747,081,862.42 |
| Sub-Total of Non-Current Assets |
48,502,704,698.19 |
| Total Assets |
70,683,518,527.34 |
| Short-Term Loans |
3,086,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,486,055,932.34 |
| Accounts Payable |
8,523,082,004.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,227,163,110.80 |
| Taxes Payable |
684,503,977.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,668,328,213.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,310,820,535.80 |
| Other Current Liabilities |
312,470,458.07 |
| Sub-Total of Current Liabilities |
20,724,670,637.99 |
| Long-term Loans |
12,893,548,447.64 |
| Bonds Payable |
2,664,662,384.05 |
| Long-Term Accounts Payable |
690,944,408.98 |
| Special Payable |
-- |
| Estimatied Liabilities |
886,417,379.27 |
| Deferred Income Tax Liabilities |
789,298.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
17,954,591,706.21 |
| Total Liabilities |
38,679,262,344.20 |
| Paid-In Capital(Or Share Stock) |
2,405,000,000.00 |
| Capital Surplus |
66,562,420.89 |
| Surplus Reserve |
2,400,716,792.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
20,421,351,459.94 |
| Minority Stockholder's Interest |
3,603,918,261.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
28,400,337,921.16 |
| Owner's Equity（Stockholder's Equity） |
32,004,256,183.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
70,683,518,527.34 |
